Latest News & Features
article
Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets. 28 February 2023
article
The move marks the firm’s second western merger this year | Joining firm has a strong presence in Denver and Asia markets. 28 February 2023
Big Pharma
Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel. 28 February 2023
Asia-Pacific
New recruit joins from DLA Piper and will head up firm’s litigation team | Previously worked on Pfizer v Samsung Bioepis, Jusand v Rattlejack & Murray Engineering, and Pfizer v Sandoz | Follows prosecutor Chris Vindurampulle who joined in October last year. 23 February 2023
Medtech
California-based company claims materials engineer emailed himself confidential information | Trade secrets related to artificial heart valve materials. 23 February 2023
Big Pharma
Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices. 23 February 2023
Biotechnology
Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19. 21 February 2023
Big Pharma
Case focuses on the enablement scope of patents | Amici curiae argue Amgen patents are too broad | Pfizer | Eli Lilly | AstraZeneca| Sanofi | Genentech | Bayer | Gilead Sciences| Johnson & Johnson. 21 February 2023
article
The move is part of a strategic plan, with a focus on patents. 15 February 2023
Americas
The pharma company is accused of using patented tech for a drug-delivery system without authorisation | Moderna sought to escape the suit by claiming that its contract with the US government conferred immunity. 15 February 2023